Locations:

Tag: non-small cell lung cancer (NSCLC)

January 29, 2020/Cancer/Research

NCI Grant to Cleveland Clinic Scientist Will Support Evolution-Based Cancer Research

Searching for new insights into drug resistance, collateral sensitivity

August 20, 2019/Cancer

Immunotherapy for Non-Small Cell Lung Cancer Brain Metastases: Ready for Prime Time

Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition

February 27, 2019/Basic & Translational Science/Research

Treat the Player, Treat the Game: Targeting Cancer’s Evolutionary Strategies

An eco-evolutionary perspective

January 4, 2019/Cancer/Tumor Oncology

SELECT Trial Finds TKIs Delay Recurrence but May Not Improve Cure Rate

More time on drug may be needed

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

July 9, 2018/Cancer/Research

ALT-803 + Nivolumab Found Safe, Effective in Metastatic NSCLC

An IL-15 superagonist shows promise

September 25, 2017/Cancer/Research

Novel, Targeted Therapies for Patients with Advanced, RET-Positive NSCLC

Lenvatinib promising, trials ongoing

BackPage 2 of 2Next